RESUMO
The p53 canonical consensus sequence is a 10-bp repeat of PuPuPuC(A/T)(A/T)GPyPyPy, separated by a spacer with up to 13 bases. C(A/T)(A/T)G is the core sequence and purine (Pu) and pyrimidine (Py) bases comprise the flanking sequence. However, in the p53 noncanonical sequences, there are many variations, such as length of consensus sequence, variance of core sequence or flanking sequence, and variance in number of bases making up the spacer or AT gap composition. In comparison to p53, the p53 family members p63 and p73 have been found to have more tolerance to bind and activate several of these noncanonical sequences. The p53 protein forms monomers, dimers, and tetramers, and its nonspecific binding domain is well-defined; however, those for p63 or p73 are still not fully understood. Study of p63 and p73 structure to determine the monomers, dimers or tetramers to bind and regulate noncanonical sequence is a new challenge which is crucial to obtaining a complete picture of structure and function in order to understand how p63 and p73 regulate genes differently from p53. In this review, we will summarize the rules of p53 family non-canonical sequences, especially focusing on the structure of p53 family members in the regulation of specific target genes. In addition, we will compare different software programs for prediction of p53 family responsive elements containing parameters with canonical or non-canonical sequences.
Assuntos
Elementos de Resposta , Ativação Transcricional , Proteína Supressora de Tumor p53/química , Proteína Supressora de Tumor p53/metabolismo , Animais , Sequência de Bases , Sítios de Ligação , Sequência Consenso , Regulação da Expressão Gênica , Variação Genética , Humanos , Família Multigênica , Ligação Proteica , Multimerização Proteica , Relação Estrutura-Atividade , Proteína Supressora de Tumor p53/genéticaRESUMO
The canonical core sequence of the p53 response element, CATG, has a two-base A/T gap. Previously, we found that p53 can also activate a non-canonical four-base A/T gap CATATG core sequence. In this study, we investigated the possible number of A/T bases used by p53 and showed that a six-base A/T gap CATATATG core sequence was the maximum A/T gap in the p53 response element that could be upregulated by p53 and p63. Canonical and non-canonical p53 response elements also have three-base flanking sequences. A/T bases could be substituted by G/C bases, including CACACG and CGTGTG, but not CGCGCG. We found that the SV40 promoter with functional six- and two-base A/T gap core sequences could be activated by TAp63γ and that TAp63γ could upregulate SV40 small and large T antigens expression in COS7 cells. We also found that the distal region of PUMA promoter with functional two six-base A/T gap core sequences could be activated by TAp63γ in 293T cells. These new findings could provide novel rules for the non-canonical p53 family response element and could extend the entire p53 family regulation network.
Assuntos
Regulação da Expressão Gênica/fisiologia , Redes Reguladoras de Genes/fisiologia , Elementos de Resposta/fisiologia , Proteína Supressora de Tumor p53/metabolismo , Animais , Células COS , Linhagem Celular , Chlorocebus aethiops , Humanos , Fatores de Transcrição/genética , Fatores de Transcrição/metabolismo , Proteína Supressora de Tumor p53/genética , Proteínas Supressoras de Tumor/genética , Proteínas Supressoras de Tumor/metabolismoRESUMO
During epidermal cell differentiation, keratin 14 (K14) expression is down-regulated, p53 expression varies, and the expression of the p53 target genes, p21 and 14-3-3σ, increases. These trends suggest that the relative transcriptional activity of p53 is increased during epidermal cell differentiation. To determine the relationship between K14 and p53, we constructed K14 promoters of various sizes and found that wild-type p53 could repress the promoter activity of all of the K14 promoter constructs in H1299 cells. K14-p160 contains an SP1 binding site mutation that prevents p53 from repressing K14 expression. Using a DNA affinity precipitation assay, we confirmed that p53 forms a complex with SP1 at the SP1 binding site between nucleotides -48 and -43 on the K14 promoter. Thus, our data indicate that p53 acts as a co-repressor to down-regulate K14 expression by binding to SP1. Next, we used a 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced epidermal cell differentiation model to examine the inhibition of K14 expression caused by increased p53 activity. Human ovarian teratocarcinoma C9 cells were treated with TPA to induce differentiation. Over-expression of the dominant negative p53 mutant ΔTAp53, which inhibits p53 activity, prevented the TPA-induced K14 down-regulation in C9 cells. Furthermore, treatment of normal primary human foreskin keratinocytes (PHFK) with the p53 inhibitor pifithrin-α (PFT-α) showed that the inhibition of p53 activity relieves K14 repression during epidermal cell differentiation. Finally, we found that TPA induces the phosphorylation of p53 at residue 378, which enhances the affinity of p53 to bind to Sp1 and repress K14 expression.
Assuntos
Diferenciação Celular/genética , Proteínas Correpressoras/metabolismo , Células Epidérmicas , Regulação da Expressão Gênica , Queratina-14/genética , Proteína Supressora de Tumor p53/metabolismo , Pareamento de Bases/genética , Sequência de Bases , Benzotiazóis/farmacologia , Diferenciação Celular/efeitos dos fármacos , Células Cultivadas , Prepúcio do Pênis/citologia , Regulação da Expressão Gênica/efeitos dos fármacos , Genes Dominantes/genética , Humanos , Queratina-14/metabolismo , Queratinócitos/citologia , Queratinócitos/efeitos dos fármacos , Queratinócitos/metabolismo , Masculino , Modelos Biológicos , Dados de Sequência Molecular , Proteínas Mutantes/metabolismo , Fosforilação/efeitos dos fármacos , Regiões Promotoras Genéticas/genética , Ligação Proteica/efeitos dos fármacos , Fator de Transcrição Sp1/metabolismo , Acetato de Tetradecanoilforbol/farmacologia , Tolueno/análogos & derivados , Tolueno/farmacologia , Proteína Supressora de Tumor p53/antagonistas & inibidores , Regulação para Cima/efeitos dos fármacos , Regulação para Cima/genéticaRESUMO
Three members of p53 family, p53, p63 and p73, can transactivate their specific target genes through a p53 consensus sequence-binding motif which consists with direct repeats of PuPuPuC(T/A)(T/A)GPyPyPy as a whole-site of p53-binding site. p63, an epidermal stem cells marker, can regulate epidermal development and differentiation, but p53 has no similar biological activity. One isoform of p63, TAp63α, can active an epidermal basal cell marker, keratin 14. However, the p53-binding site does not exist as a whole-site in the K14 promoter region, although it contains three putative p53 half-binding sites at -269 to -1 of the K14 promoter. Two of three putative half-sites of the p53-binding site can be bound by p63α by electrophoresis mobility shift assay and DNA affinity purification assay. Only mutation of the p53 half-binding site at -140 to -131, the TAp63α induced K14 promoter activity can be abolished. This half-site was specifically activated by p63, but not by p53. Once we extend this p53 half-site to a whole p53-binding site in K14 promoter, both p53 and p63 expression vectors can activate its activity. Therefore, we propose that the different length of p53-binding site would determinate the gene regulated by different p53 family proteins.
Assuntos
Queratina-14/genética , Regiões Promotoras Genéticas , Fatores de Transcrição/metabolismo , Proteína Supressora de Tumor p53/metabolismo , Proteínas Supressoras de Tumor/metabolismo , Sequência de Bases , Sítios de Ligação , Células HeLa , Humanos , Queratina-14/metabolismo , Dados de Sequência Molecular , Fatores de Transcrição/genética , Proteína Supressora de Tumor p53/química , Proteínas Supressoras de Tumor/genéticaRESUMO
The consensus sequence of p53 is repeated half sites of PuPuPuC(A/T)(A/T)GPyPyPy. GtAGCAttAGCCCAGACATGTCC is a 14-3-3sigma promoter p53 regulation site; the first core sequence is CAttAG, and the second is CATG. Both mutants GtAGgAttAGCCCAGACATGTCC and GtAGCAttAGCCCAGACATcTCC can be activated by p53 as a 1.5-fold half site. The original p53 regulated site on the 14-3-3sigma promoter is a whole site, and CATTAG is a functional core sequence. The p53-binding affinity and the activity of CATTAG were lower than for the mutant CATATG core sequence. Wild-type p53 acts as a tetramer to bind to the whole site; however, it also can bind to a half site by one of its dimers. Wild-type p53 can only bind to a half site with core sequence CATG but not to CATATG. The 1.5-fold half site or whole site with core sequence CATATG can be bound by wild-type p53. A p53 mutant, A344, forms dimeric p53; it can only bind to CATG, and not to CATATG. Therefore, tetrameric and dimeric p53 can bind to a two-base A/T gap core sequence, but only tetrameric p53 can bind to a four-base A/T gap core sequence.
Assuntos
Elementos de Resposta , Proteína Supressora de Tumor p53/metabolismo , Proteínas 14-3-3/genética , Sequência de Bases , Sítios de Ligação , Linhagem Celular , Sequência Consenso , Humanos , Regiões Promotoras Genéticas , Multimerização Proteica , Proteína Supressora de Tumor p53/químicaRESUMO
Several different in vivo and in vitro bioassays are used to evaluate melanosome transfer efficacy from melanocytes to keratinocytes. However, these methods are complicated and time consuming. Here, we report on a simple, rapid, direct, and reliable in vitro method for observing the process of melanosome transfer from melanocytes to keratinocytes. First, we selected and tested a melanoma cell line RPMI-7951 that can normally synthesize melanin and transfer from mature melanosomes to keratinocytes in vitro. We cocultured these cells with a human ovarian teratoma transformed epidermal carcinoma cell line, which is also capable of accepting melanosomes transferred from melanocytes, as in normal keratinocytes. The cells were cocultured for 24-72 h and double labeled with FITC-conjugated antibody against the melanosome-associated protein TRP-1, and with Cy5-conjugated antibody against the keratinocyte-specific marker keratin 14. The cells were examined by fluorescence microscope and flow cytometry. Melanosome transfer from melanocytes to keratinocytes increased in a time-dependent manner. To verify the accessibility of this method, the melanosome transfer inhibitor, a serine protease inhibitor, 4-(2-aminoethyl) benzenesulfonyl fluoride hydrochloride, and a melanosome transfer stimulator, alpha-melanocyte-stimulating hormone, were added. The serine protease inhibitor decreased melanosome transfer, and alpha-melanocyte-stimulating hormone increased melanosome transfer, in a dose-dependent manner. In conclusion, this is a simple, rapid, and effective model system to quantify the melanosome transfer efficacy from melanocytes to keratinocytes in vitro.
Assuntos
Bioensaio/métodos , Queratinócitos/metabolismo , Melanócitos/metabolismo , Melanossomas/metabolismo , Técnicas de Cultura de Células , Linhagem Celular , Técnicas de Cocultura , Humanos , Queratinócitos/citologia , Queratinócitos/efeitos dos fármacos , Melanócitos/citologia , Melanócitos/efeitos dos fármacos , Melanossomas/efeitos dos fármacos , Oxirredutases/metabolismo , Inibidores de Serina Proteinase/farmacologia , Sulfonas/farmacologia , alfa-MSH/farmacologiaRESUMO
BACKGROUND: We have demonstrated that uraemic neutrophils that exhibit a low intracellular pH (pHi) display enhanced phagocytosis. However, the underlying cellular mechanism is unclear. METHODS: We used neutrophils from three groups of haemodialysis (HD) patients before dialysis (Groups A, B and C) and also from age- and sex-matched healthy individuals to determine pHi, phagocytosis and expression of CD11b, CD18, CD14 and toll-like receptors (TLR)-2 and TLR-4. The patients were categorized based on three consecutive monthly pre-dialysis plasma bicarbonate concentrations(P(HCO3)) and pH values; Groups A, B and C had a constant pre-dialysis P(HCO3) of =21, 21-26 and >/=26 mmol/L (mEq/L), respectively. We also studied the effects induced by the correction of metabolic acidosis and monoclonal antibodies (mAbs) against CD11b/CD18 on neutrophils in Group A. Furthermore, we investigated the effect of intracellular acidification on uraemic neutrophils ex vivo. RESULTS: We observed that the neutrophils in Group A exhibited significantly increased phagocytosis and expression of CD11b/CD18 compared with those in Groups B and C. Additionally, our ex vivo studies demonstrated that the mAbs against CD11b/CD18 partially blocked the enhancement of neutrophil phagocytosis in Group A. Moreover, the pHi of uraemic neutrophils is inversely correlated with phagocytosis and expression of CD11b/CD18. CONCLUSIONS: HD patients with a low P(HCO3) exhibited low neutrophil pHi that in turn increased the expression of CD11b/CD18 compared with neutrophils with a normal or high pHi. This increased expression of CD11b/CD18 on the uraemic neutrophils may contribute to the pHi-mediated phagocytosis.
Assuntos
Antígeno CD11b/sangue , Antígenos CD18/sangue , Neutrófilos/imunologia , Neutrófilos/metabolismo , Fagocitose/imunologia , Fagocitose/fisiologia , Diálise Renal/efeitos adversos , Adulto , Idoso , Anticorpos Monoclonais/farmacologia , Bicarbonatos/sangue , Estudos de Casos e Controles , Feminino , Humanos , Concentração de Íons de Hidrogênio , Líquido Intracelular/metabolismo , Masculino , Pessoa de Meia-Idade , Transdução de Sinais , Uremia/sangue , Uremia/imunologia , Uremia/terapiaRESUMO
According to previous studies, endothelin-1 (ET-1) is the most potent growth factor in the regulation of vascular smooth muscle cell (VSMC) proliferation in spontaneously hypertensive rats (SHR). To evaluate if the dominant effect of ET-1-induced VSMC proliferation is achieved by autocrine regulation, aortic smooth muscle cells from four-week-old SHR and WKY (Wistar-Kyoto) rats were cultured in 24-well dishes, and the effects of ET-1 on VSMC proliferation were determined by (a) 3H-thymidine incorporation assays with different ET-1 blocking treatments, including a specific anti-ET-1 antibody; BQ-123, an ETA receptor blocker; and BQ-788, an ETB receptor blocker; and (b) examining the ET-1 blockade on the effects of treatment with other growth factors, including thrombin and angiotension II (AT-II). These results demonstrated that the anti-ET-1 antibody, BQ-123, BQ-788, and BQ-123 plus BQ-788 all caused dose-dependent inhibition of proliferation. A 90% inhibitory effect was observed at the maximum doses used except for BQ-123. The ET-1 receptor blockers inhibited thrombin-induced VSMC growth; however, they did not efficiently inhibit AT-II-induced VSMC growth. These results indicate that the autocrine effects of ET-1 play a predominant role in the proliferation of VSMCs from SHR and WKY rats. They also suggest that thrombin-induced VSMC growth is mediated by the autocrine effects of ET-1, and angiotensin II-induced VSMC growth is mediated by other signal pathways.
Assuntos
Comunicação Autócrina/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Endotelina-1/administração & dosagem , Músculo Liso Vascular/citologia , Miócitos de Músculo Liso/efeitos dos fármacos , Angiotensina II/administração & dosagem , Animais , Anti-Hipertensivos/administração & dosagem , Aorta Torácica/citologia , Relação Dose-Resposta a Droga , Antagonistas dos Receptores de Endotelina , Hemostáticos/administração & dosagem , Masculino , Oligopeptídeos/administração & dosagem , Oligopeptídeos/antagonistas & inibidores , Peptídeos Cíclicos/administração & dosagem , Peptídeos Cíclicos/antagonistas & inibidores , Piperidinas/administração & dosagem , Piperidinas/antagonistas & inibidores , Ratos , Ratos Endogâmicos SHR , Ratos Endogâmicos WKY , Receptores de Endotelina/administração & dosagem , Transdução de Sinais/efeitos dos fármacos , Trombina/administração & dosagem , Vasoconstritores/administração & dosagemRESUMO
Hereditary nonpolyposis colorectal cancer (HNPCC) is an autosomal inherited cancer syndrome characterized by germline plus somatic mutations of DNA mismatch repair genes and familial clustering of cancers of colorectum and other visceral organs. So far, to our knowledge, there has been no proof of nonepithelial tumors in association with HNPCC. Here we report on a MSH2 frameshift HNPCC family with a carrier found to have multiple primary tumors, including endometrial hyperplasia, ovarian adenocarcinoma, skin cavernous hemangioma, and skin dermatofibrosarcoma protuberans (DFSP). We studied the replication error (RER) phenotype in noncoding (Bat-26, Bat-25, D2S123, D5S346, and D17S250) and coding (MSH3, MSH6, BAX, and TGFBR2 genes) DNA sequences, and characterized the germline and somatic mutations of the MSH2 gene in the tumors described above and in endometrial carcinomas from two of her affected siblings. RER was observed in an order of hyperplasic endometrium (6/10 markers), ovarian carcinoma (5/10 markers), endometrial carcinomas (4/9 and 3/10), DFSP (2/9 markers), and cavernous hemangioma (2/10 markers). All the tumors showed the same germline mutation of G5-->G6 frameshift at 183-187 and polymorphism of C1168T in a heterozygous pattern. In an endometrial carcinoma, deletion of the second allele of MSH2 was evident. Heterogeneous RER patterns were noted in multiple primary tumors of the same individual and in premalignant and malignant endometrial tumors from different individuals. The study demonstrated the two hits of the hMSH(2) gene as well as intra- and interindividual variations of RER phenotypes in HNPCC. The first characterized nonepithelial tumors in HNPCC seem to carry a limited panel of RER, including a framesift at the (A)(10) tract of TGFBR2.
Assuntos
Neoplasias Colorretais Hereditárias sem Polipose/genética , Neoplasias Colorretais Hereditárias sem Polipose/patologia , Replicação do DNA/genética , Proteínas de Ligação a DNA/genética , Mutação em Linhagem Germinativa/genética , Mutação/genética , Proteínas Proto-Oncogênicas/genética , Neoplasias Cutâneas/genética , Adulto , Pareamento Incorreto de Bases , DNA de Neoplasias/sangue , DNA de Neoplasias/genética , DNA de Neoplasias/isolamento & purificação , Feminino , Mutação da Fase de Leitura/genética , Humanos , Mucosa Intestinal/patologia , Masculino , Proteína 2 Homóloga a MutS , Segunda Neoplasia Primária/genética , Linhagem , Reação em Cadeia da Polimerase , Neoplasias Cutâneas/patologiaRESUMO
The effect of endothelium-released vasoactive factors on vascular smooth muscle cell (VSMC) proliferation was studied in a coculture system. Isolated aortic endothelial cells and smooth muscle cells from 4-week-old spontaneously hypertensive rats (SHR) and age-matched Wistar-Kyoto (WKY) rats were cocultured. After coculture, the VSMC proliferation rate was examined by 3H-thymidine incorporation assay and the levels of the vasoactive factors in medium were determined by enzyme immunoassay (EIA). The results indicate that the proliferation rate of VSMCs in SHR was significantly higher than in WKY rats when VSMCs were cultured alone. When SHR vascular endothelial cells (VECs) were cocultured with VSMCs, the proliferation rate of SHR VSMCs was enhanced; however, there was no growth promoting effect in WKY VSMCs. When WKY VECs were cocultured with VSMCs, no VSMC proliferation effect was observed. When VSMCs were cultured alone, the endothelin-1 (ET-1) secretion in SHR was significantly higher than in WKY rats. When VECs and VSMCs were cocultured, the ET-1 concentration increased in both SHR VEC and WKY VEC coculture groups in a similar manner; but the SHR VECs tended to release more thromboxaneA2 (TXA2) and less PGI2 than WKY VECs. These results suggest that some kind of interaction between SHR VSMCs and SHR VECs is responsible for the high proliferation of SHR VSMCs but not the effects of SHR VECs per se.
Assuntos
Células Endoteliais/fisiologia , Miócitos de Músculo Liso/fisiologia , Animais , Técnicas de Cocultura , Células Endoteliais/metabolismo , Endotelina-1/metabolismo , Endotelina-1/fisiologia , Epoprostenol/metabolismo , Epoprostenol/fisiologia , Técnicas Imunoenzimáticas , Masculino , Miócitos de Músculo Liso/metabolismo , Ratos , Ratos Endogâmicos SHR , Ratos Endogâmicos WKY , Tromboxano A2/metabolismo , Tromboxano A2/fisiologiaRESUMO
The general histology and ultrastructure of the tongue and anterior process of the sublingual plica of four Taiwanese venomous snakes, the Chinese cobra (Naja naja atra), banded krait (Bungarus multicinctus), Taiwan habu (Trimeresurus mucrosquamatus), and bamboo snake (Trimeresurus stejnegeri stejnegeri) are described. The tongue fork exhibits a mid-dorsal invagination that broadens gradually toward its base. No mid-ventral invagination is observed. The epithelial cells on both dorsal and ventral aspects of the tongue fork have large and small microfacets, micropores and microvilli. The cell size, distribution pattern of the large microfacets, and the number of small microfacets present on both sides of the fork are essentially the same within a species, but vary among species. The function of these ultrastructures on the cell surface might be for the capture of chemical substances. The large microfacets are raised areas of the cell membrane, each with a pale granule contained within. The chemical nature of the pale granule is not yet known. The small pores surrounding the large microfacets are shallow hollows left after the release of the pale granules from the microfacets. The basic histological pattern of the tongue fork of these species is similar, being composed of a mucosal layer outside and dense musculature inside. No taste buds are discernible. The anterior processes are concave-like expansions of the anteriormost portions of the sublingual plicae. The oblique folds and micropapillae of this organ might be helpful for receiving the chemicals collected on the tongue, when the tongue makes contact with the elevated processes. The elevated processes may penetrate the ducts of Jacobson's organs to effect the final transfer.